Hepatorenal Syndrome: A Severe, but Treatable, Cause of Kidney Failure in Cirrhosis
American Journal of Kidney Diseases, 04/10/2012Fagundes C et al.
A liver transplant is the preferred treatment for Hepatorenal syndrome (HRS). Pharmacologic treatment with vasoconstrictors to reverse splanchnic vasodilation, together with albumin, is effective in 40%–50% of patients with type 1 HRS and improves survival. The drug of choice is the vasopressin analogue terlipressin. Renal replacement therapy should not be used as first–line therapy.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.